Similar results were obtained in a earlier study involving the massively parallel sequencing of 22 lung adenocarcinoma specimens, which revealed that EGFR mutations can be very heterogeneous in a single tumor sample and that certain mutations were only present in <10% of total sequences (15). Here, EGFR is linked to lung adenocarcinoma.